Literature DB >> 11160746

Kaposi's sarcoma-associated herpesvirus can productively infect primary human keratinocytes and alter their growth properties.

F Cerimele1, F Curreli, S Ely, A E Friedman-Kien, E Cesarman, O Flore.   

Abstract

Previous studies have shown the presence of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8) DNA in endothelial cells, in keratinocytes in the basal layer of the epidermis overlying plaque-stage nodular lesions of cutaneous Kaposi's sarcoma (KS), and in the epithelial cells of eccrine glands within KS lesions. We infected primary cell cultures of human keratinocytes with KSHV/HHV8. At 6 days post infection, transcription of viral genes was detected by reverse transcriptase PCR (RT-PCR), and protein expression was documented by an immunofluorescence assay with an anti-LANA monoclonal antibody. To determine whether the viral lytic cycle was inducible by chemical treatment, KSHV/HHV8-infected keratinocytes were treated with 12-O-tetradecanoylphorbol-13-acetate (TPA) and RT-PCR was performed to confirm the transcription of lytic genes such as open reading frame 26, (which encodes a capsid protein). Finally, to assess infectious viral production, other primary human cells (human umbilical vein endothelial cells), were infected with concentrated supernatant of KSHV-infected, TPA-induced keratinocytes and the presence of viral transcripts was confirmed by RT-PCR. The uninfected keratinocytes senesced 3 to 5 weeks after mock infection, while the KSHV/HHV8-infected keratinocytes continued to proliferate and to date are still in culture. However, 8 weeks after infection, viral genomes were no longer detectable by nested PCR. Although the previously KSHV/HHV8-infected keratinocytes still expressed epithelial markers, they acquired new characteristics such as contact inhibition loss, telomerase activity, anchorage-independent growth, and changes in cytokine production. These results show that KSHV/HHV8, like other herpesviruses, can infect and replicate in epithelial cells in vitro and suggest that in vivo these cells may play a significant role in the establishment of KSHV/HHV8 infection and viral transmission.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160746      PMCID: PMC114826          DOI: 10.1128/JVI.75.5.2435-2443.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes.

Authors:  Y Chang; C H Tung; Y T Huang; J Lu; J Y Chen; C H Tsai
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  In situ polymerase chain reaction-based localization studies support role of human herpesvirus-8 as the cause of two AIDS-related neoplasms: Kaposi's sarcoma and body cavity lymphoma.

Authors:  K E Foreman; P E Bacon; E D Hsi; B J Nickoloff
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

3.  Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma.

Authors:  K E Foreman; J Friborg; W P Kong; C Woffendin; P J Polverini; B J Nickoloff; G J Nabel
Journal:  N Engl J Med       Date:  1997-01-16       Impact factor: 91.245

4.  Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma.

Authors:  R Masood; J Cai; T Zheng; D L Smith; Y Naidu; P S Gill
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-04       Impact factor: 11.205

5.  Cytokine signaling through the novel tyrosine kinase RAFTK in Kaposi's sarcoma cells.

Authors:  Z Y Liu; R K Ganju; J F Wang; M A Ona; W C Hatch; T Zheng; S Avraham; P Gill; J E Groopman
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

6.  Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma.

Authors:  E Cornali; C Zietz; R Benelli; W Weninger; L Masiello; G Breier; E Tschachler; A Albini; M Stürzl
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

7.  Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.

Authors:  E T Lennette; D J Blackbourn; J A Levy
Journal:  Lancet       Date:  1996-09-28       Impact factor: 79.321

8.  Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus.

Authors:  L Arvanitakis; E A Mesri; R G Nador; J W Said; A S Asch; D M Knowles; E Cesarman
Journal:  Blood       Date:  1996-10-01       Impact factor: 22.113

9.  Cytomegalovirus infection induces expression of 60 KD/Ro antigen on human keratinocytes.

Authors:  J Zhu
Journal:  Lupus       Date:  1995-10       Impact factor: 2.911

10.  Intermediate- and low-molecular-weight keratin detection with the monoclonal antibody MNF116. An immunohistochemical study on 232 paraffin-embedded cutaneous lesions.

Authors:  V G Prieto; J Lugo; N S McNutt
Journal:  J Cutan Pathol       Date:  1996-06       Impact factor: 1.587

View more
  25 in total

1.  Transcriptional regulation of the K1 gene product of Kaposi's sarcoma-associated herpesvirus.

Authors:  Brian S Bowser; Scott M DeWire; Blossom Damania
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 2.  Molecular biology of KSHV in relation to AIDS-associated oncogenesis.

Authors:  Whitney Greene; Kurt Kuhne; Fengchun Ye; Jiguo Chen; Fuchun Zhou; Xiufen Lei; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2007

3.  Productive lytic replication of a recombinant Kaposi's sarcoma-associated herpesvirus in efficient primary infection of primary human endothelial cells.

Authors:  Shou-Jiang Gao; Jian-Hong Deng; Fu-Chun Zhou
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 4.  Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis.

Authors:  Qiliang Cai; Suhbash C Verma; Jie Lu; Erle S Robertson
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

5.  Infection of primary human tonsillar lymphoid cells by KSHV reveals frequent but abortive infection of T cells.

Authors:  Jinjong Myoung; Don Ganem
Journal:  Virology       Date:  2011-02-25       Impact factor: 3.616

6.  Modulation of host gene expression by the K15 protein of Kaposi's sarcoma-associated herpesvirus.

Authors:  Melanie M Brinkmann; Marcel Pietrek; Oliver Dittrich-Breiholz; Michael Kracht; Thomas F Schulz
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

7.  Use of a BJAB-derived cell line for isolation of human herpesvirus 8.

Authors:  Paola Gasperini; Massimo Barbierato; Canio Martinelli; Paolo Rigotti; Francesco Marchini; Giulia Masserizzi; Francesco Leoncini; Luigi Chieco-Bianchi; Thomas F Schulz; Maria Luisa Calabrò
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

8.  Kaposi's sarcoma-associated herpesvirus ORF18 and ORF30 are essential for late gene expression during lytic replication.

Authors:  Danyang Gong; Nicholas C Wu; Yafang Xie; Jun Feng; Leming Tong; Kevin F Brulois; Harding Luan; Yushen Du; Jae U Jung; Cun-yu Wang; Mo Kwan Kang; No-Hee Park; Ren Sun; Ting-Ting Wu
Journal:  J Virol       Date:  2014-07-23       Impact factor: 5.103

Review 9.  Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases.

Authors:  Dharam V Ablashi; Louise G Chatlynne; James E Whitman; Ethel Cesarman
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

10.  Human herpesvirus 8 infects and replicates in primary cultures of activated B lymphocytes through DC-SIGN.

Authors:  Giovanna Rappocciolo; Heather R Hensler; Mariel Jais; Todd A Reinhart; Amarendra Pegu; Frank J Jenkins; Charles R Rinaldo
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.